Protein aggregation occurs in association with a variety of liver diseases and is typically cytoplasmic. A common form of protein aggregates are Mallory-Denk bodies (MDBs) that are found in association with steatohepatitis, viral hepatitis and other forms of liver disease. Recent findings indicate that the presence of MDBs provides an independent poor clinical and histological outcome in patients with hepatitis C. The propensity to form MDBs is linked to the genetic background as supported by higher predisposition to their formation in specific mouse (C57BL >C3H strain) and human (Hispanic >White) genotypes. Among the molecular alterations that positively associate with experimental MDB formation are hypersumoylation and hypoacetylation of keratins (the major protein constituents of MDBs). Also, the overall liver sumoylation is impaired in the C57BL MDB-susceptible strain. Another potential genetic modifier we identified is the ecto-5'- nucleotidase, CD73, whereby a novel and hitherto unknown spliced variant is modulated differently in the MDB formation-prone versus formation-resistant strains. Aside from the cytoplasmic MDBs, a novel type of nuclear protein aggregation that we recently observed in cell culture, in mouse liver injury models undergoing oxidative stress, and in some human chronic liver disease explants involves the nuclear lamins. Formation of lamin- containing aggregates is rapid and is noted within days of exposure to the insult;and is observed prior to MDB formation, which requires weeks. Lamin aggregation could interfere with one or more nuclear functions, and its rapid onset may serve as an early marker of specific types of oxidative injury. Our hypothesis is that genetic variations unmask differences in hepatocyte responses to oxidative injury which manifest as nuclear and cytoplasmic protein aggregation. This hypothesis will be tested using 3 specific aims: (i) Characterize the role of CD73 in strain-selective MDB formation and liver injury;(ii) Characterize keratin acetylation and its relationship to keratin sumoylation and aggregation during oxidative stress;and (iii) Define the biochemical and functional alterations that associate with nuclear lamin disorganization in response to liver injury. Completion of our aims should provide fundamental knowledge regarding genetic modifiers and posttranslational regulation involved in MDB formation. In addition, the exciting finding of a novel CD73 isoform and its genetic background-related differences in response to liver injury may unfold a new paradigm for the role of CD73 in liver and other cell responses to injury. Furthermore, the newly appreciated aggregation of nuclear lamins in response to liver injury provides a potential novel mechanism for direct nuclear involvement that may protect from or promote liver injury, with consequent possible therapeutic, prognostic and diagnostic targets and approaches.

Public Health Relevance

The overarching goal of this proposal is to identify genetic influences on the predisposition to protein aggregation in response to oxidative liver injury. Understanding the role of genetic factors is highly beneficial and relevant since it provides potential diagnostic, prognostic and therapeutic targets in human liver disease, in addition to providing possible molecular explanations to the observed differences in susceptibility to a range of liver diseases in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052951-17
Application #
8719971
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Serrano, Jose
Project Start
1997-09-01
Project End
2016-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
17
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Physiology
Type
Schools of Medicine
DUNS #
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Omary, M Bishr (2017) Intermediate filament proteins of digestive organs: physiology and pathophysiology. Am J Physiol Gastrointest Liver Physiol 312:G628-G634
Zhang, Deqiang; Tong, Xin; VanDommelen, Kyle et al. (2017) Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity. J Clin Invest 127:2855-2867
Ajluni, Nevin; Meral, Rasimcan; Neidert, Adam H et al. (2017) Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. Clin Endocrinol (Oxf) 86:698-707
Ku, Nam-On; Strnad, Pavel; Bantel, Heike et al. (2016) Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology 64:966-76
Snider, Natasha T; Portney, Daniel A; Willcockson, Helen H et al. (2016) Ethanol and Acetaminophen Synergistically Induce Hepatic Aggregation and TCH346-Insensitive Nuclear Translocation of GAPDH. PLoS One 11:e0160982
Elenbaas, Jared S; Maitra, Dhiman; Liu, Yang et al. (2016) A precursor-inducible zebrafish model of acute protoporphyria with hepatic protein aggregation and multiorganelle stress. FASEB J 30:1798-810
Weerasinghe, Sujith V W; Park, Min-Jung; Portney, Daniel A et al. (2016) Mouse genetic background contributes to hepatocyte susceptibility to Fas-mediated apoptosis. Mol Biol Cell 27:3005-3012
Gilbert, St├ęphane; Loranger, Anne; Omary, M Bishr et al. (2016) Keratin impact on PKC?- and ASMase-mediated regulation of hepatocyte lipid raft size - implication for FasR-associated apoptosis. J Cell Sci 129:3262-73
Snider, Natasha T; Omary, M Bishr (2016) Assays for Posttranslational Modifications of Intermediate Filament Proteins. Methods Enzymol 568:113-38
Sun, Jingyuan; Groppi, Vincent E; Gui, Honglian et al. (2016) High-Throughput Screening for Drugs that Modulate Intermediate Filament Proteins. Methods Enzymol 568:163-85

Showing the most recent 10 out of 82 publications